Telix
1 products tracked · names used in filings: Telix
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 11 Sep 2026🇺🇸 FDA approval
FDA approves Pixclara (floretyrosine f-18), a new medicine
Telix; NDA218592; New molecular entity, Priority review; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Pixclara floretyrosine f-18 | Approved | 2026-09-11 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.